Sanne P Smeekens1, Mark S Gresnigt1, Katharina L Becker1, Shih-Chin Cheng1, Stejara A Netea1, Liesbeth Jacobs1, Trees Jansen1, Frank L van de Veerdonk1, David L Williams2, Leo A B Joosten1, Charles A Dinarello3, Mihai G Netea4. 1. Department of Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Nijmegen Institute for Infection, Inflammation, and Immunity (N4i), Nijmegen, The Netherlands. 2. Department of Surgery, Quillen College of Medicine, East Tennessee State University, TN, USA. 3. Department of Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Department of Medicine, University of Colorado, Denver, CO, USA. 4. Department of Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Nijmegen Institute for Infection, Inflammation, and Immunity (N4i), Nijmegen, The Netherlands. Electronic address: m.netea@aig.umcn.nl.
Abstract
BACKGROUND: Candida albicans is an opportunistic fungal pathogen that induces strong proinflammatory responses, such as IL-1β production. Much less is known about the induction of immune modulatory cytokines, such as the IL-1 receptor antagonist (IL-1Ra) that is the main natural antagonist of IL-1, by C. albicans. METHODS: Peripheral blood mononuclear cells (PBMC) of healthy individuals were stimulated with C. albicans and different components of the fungal cell wall. The role of pathogen recognition receptors (PRRs) for the induction of IL-1β and IL-1Ra was investigated by using specific blockers or in PBMC from Dectin-1 deficient patients. RESULTS: C. albicans induced a strong IL-1Ra response, and this induction was primarily induced by the cell-wall component β-glucan. Blocking IL-1Ra significantly increased C. albicans β-glucan hyphae induced IL-1β and IL-6 production. Surprisingly, blocking the β-glucan receptor Dectin-1 or the downstream Syk or Raf-1 pathways only marginally reduced C. albicans-induced IL-1Ra production, while blocking of the complement receptor 3 (CR3), TLR2 or TLR4 had no effect. In line with this, blocking MAP kinases had little effect on Candida-induced IL-1Ra production. PBMC isolated from Dectin-1 deficient patients produced normal IL-1Ra amounts in response to C. albicans stimulation. Interestingly, the IL-1Ra synthesis induced by β-glucan was blocked by inhibitors of the Akt/PI3K pathway. CONCLUSIONS: β-glucan of C. albicans induces a strong IL-1Ra response, which is independent of the β-glucan receptors dectin-1 and CR3. These data strongly argue for the existence of an unknown β-glucan receptor that specifically induces an Akt/PI3K-dependent anti-inflammatory IL-1Ra response upon recognition of C. albicans.
BACKGROUND:Candida albicans is an opportunistic fungal pathogen that induces strong proinflammatory responses, such as IL-1β production. Much less is known about the induction of immune modulatory cytokines, such as the IL-1 receptor antagonist (IL-1Ra) that is the main natural antagonist of IL-1, by C. albicans. METHODS: Peripheral blood mononuclear cells (PBMC) of healthy individuals were stimulated with C. albicans and different components of the fungal cell wall. The role of pathogen recognition receptors (PRRs) for the induction of IL-1β and IL-1Ra was investigated by using specific blockers or in PBMC from Dectin-1deficientpatients. RESULTS:C. albicans induced a strong IL-1Ra response, and this induction was primarily induced by the cell-wall component β-glucan. Blocking IL-1Ra significantly increased C. albicans β-glucan hyphae induced IL-1β and IL-6 production. Surprisingly, blocking the β-glucan receptor Dectin-1 or the downstream Syk or Raf-1 pathways only marginally reduced C. albicans-induced IL-1Ra production, while blocking of the complement receptor 3 (CR3), TLR2 or TLR4 had no effect. In line with this, blocking MAP kinases had little effect on Candida-induced IL-1Ra production. PBMC isolated from Dectin-1deficientpatients produced normal IL-1Ra amounts in response to C. albicans stimulation. Interestingly, the IL-1Ra synthesis induced by β-glucan was blocked by inhibitors of the Akt/PI3K pathway. CONCLUSIONS: β-glucan of C. albicans induces a strong IL-1Ra response, which is independent of the β-glucan receptors dectin-1 and CR3. These data strongly argue for the existence of an unknown β-glucan receptor that specifically induces an Akt/PI3K-dependent anti-inflammatory IL-1Ra response upon recognition of C. albicans.
Authors: Douglas W Lowman; Harry E Ensley; Rachel R Greene; Kevin J Knagge; David L Williams; Michael D Kruppa Journal: Carbohydr Res Date: 2011-10-02 Impact factor: 2.104
Authors: Sanne P Smeekens; Frank L van de Veerdonk; Leo A B Joosten; Liesbeth Jacobs; Trees Jansen; David L Williams; Jos W M van der Meer; Bart Jan Kullberg; Mihai G Netea Journal: Eur J Immunol Date: 2011-08-30 Impact factor: 5.532
Authors: Héctor M Mora-Montes; Mihai G Netea; Gerben Ferwerda; Megan D Lenardon; Gordon D Brown; Anita R Mistry; Bart Jan Kullberg; Chris A O'Callaghan; Chirag C Sheth; Frank C Odds; Alistair J P Brown; Carol A Munro; Neil A R Gow Journal: Infect Immun Date: 2011-02-28 Impact factor: 3.441
Authors: Shih-Chin Cheng; Frank L van de Veerdonk; Megan Lenardon; Monique Stoffels; Theo Plantinga; Sanne Smeekens; Lisa Rizzetto; Liliane Mukaremera; Kanya Preechasuth; Duccio Cavalieri; Thirumala Devi Kanneganti; Jos W M van der Meer; Bart Jan Kullberg; Leo A B Joosten; Neil A R Gow; Mihai G Netea Journal: J Leukoc Biol Date: 2011-04-29 Impact factor: 4.962
Authors: Mohlopheni J Marakalala; David L Williams; Jennifer C Hoving; Rolf Engstad; Mihai G Netea; Gordon D Brown Journal: Microbes Infect Date: 2013-03-19 Impact factor: 2.700
Authors: Mihai G Netea; Leo A B Joosten; Jos W M van der Meer; Bart-Jan Kullberg; Frank L van de Veerdonk Journal: Nat Rev Immunol Date: 2015-09-21 Impact factor: 53.106
Authors: Cody L Stothers; Katherine R Burelbach; Allison M Owen; Naeem K Patil; Margaret A McBride; Julia K Bohannon; Liming Luan; Antonio Hernandez; Tazeen K Patil; David L Williams; Edward R Sherwood Journal: J Immunol Date: 2021-11-05 Impact factor: 5.426
Authors: Mark S Gresnigt; Katharina L Becker; Floris Leenders; M Fernanda Alonso; Xiaowen Wang; Jacques F Meis; Judith M Bain; Lars P Erwig; Frank L van de Veerdonk Journal: J Innate Immun Date: 2017-12-16 Impact factor: 7.349